Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiaoer Qinggan granules
- Development stage
- Unknown
- Lead developer
- Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Xiaoer Qinggan granules is a Traditional Chinese Medicine (TCM) hospital-made preparation developed by the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine. Formulated specifically for pediatric patients, it is indicated for the treatment of influenza and upper respiratory tract infections presenting with wind-heat symptoms, such as fever, sore throat, and cough. The granule is composed of several medicinal herbs, including *Lonicera japonica* and *Forsythia suspensa*, which are known for their antipyretic, anti-inflammatory, and antiviral properties. It functions by clearing internal heat and detoxifying the body, thereby alleviating clinical symptoms and potentially inhibiting viral replication. The preparation is widely used within the Liaoning provincial hospital system as a standard of care for childhood viral infections.
- Brand names
- Xiaoer Qinggan granules
- Other names
- Xiaoer Qinggan KeliPediatric Qinggan Granules
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))NeuraminidaseIL-6 (Interleukin 6)
Beyond the preview
Go deeper on Xiaoer Qinggan granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiaoer Qinggan granules.